<DOC>
	<DOCNO>NCT02273479</DOCNO>
	<brief_summary>Study investigate pharmacokinetics , pharmacodynamics safety RAD-SP capsule multiple administration healthy adult male volunteer .</brief_summary>
	<brief_title>Pharmacokinetics Safety Asasantin Extended Release ( RAD-SP ) Capsules Japanese Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<criteria>Healthy male volunteer judge investigator appropriate subject basis screen test result Age range : ≥ 20 year ≤ 35 year Body weight 50 80 kg Obesity within ± 20 % standard body weight Ability provide write informed consent participate study History drug allergy History bronchial asthma History drug abuse alcohol abuse History hemorrhagic tendency hemorrhagic disease Volunteers experience play sport boxing may damage brain Accidents associate brain concussion contusion ( traffic accident , etc . ) Administration study drug within 4 month start administration study drug Collection whole blood ( ≥ 400 ml ) within 3 month study drug administration Collection component blood ( ≥ 400 ml ) within 1 month study drug administration Intake drug within 10 day study drug administration Excessive physical activity within last 5 day prior study drug administration Intake alcohol within 3 day study drug administration Volunteers judge investigator inappropriate subject study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>